|
US 12,077,509 B2 |
|
Compounds and methods for the targeted degradation of androgen receptor |
Hanqing Dong, Madison, CT (US); Keith R. Hornberger, Southbury, CT (US); and Lawrence B. Snyder, Killingworth, CT (US) |
Assigned to Arvinas Operations, Inc., New Haven, CT (US) |
Filed by Arvinas Operations, Inc., New Haven, CT (US) |
Filed on Jun. 22, 2023, as Appl. No. 18/213,055. |
Application 16/577,901 is a division of application No. 15/730,728, filed on Oct. 11, 2017, granted, now 10,584,101, issued on Mar. 10, 2020. |
Application 18/213,055 is a continuation of application No. 17/539,679, filed on Dec. 1, 2021, granted, now 11,952,347. |
Application 17/539,679 is a continuation of application No. 16/938,864, filed on Jul. 24, 2020, granted, now 11,236,051, issued on Feb. 1, 2022. |
Application 16/938,864 is a continuation of application No. 16/577,901, filed on Sep. 20, 2019, granted, now 10,844,021, issued on Nov. 24, 2020. |
Claims priority of provisional application 62/528,385, filed on Jul. 3, 2017. |
Claims priority of provisional application 62/406,888, filed on Oct. 11, 2016. |
Prior Publication US 2023/0331681 A1, Oct. 19, 2023 |
Int. Cl. A61K 31/166 (2006.01); A61K 31/02 (2006.01); A61K 31/277 (2006.01); A61K 31/496 (2006.01); A61K 31/497 (2006.01); A61K 31/501 (2006.01); A61K 31/506 (2006.01); A61K 45/06 (2006.01); A61K 47/10 (2017.01); C07D 205/04 (2006.01); C07D 209/48 (2006.01); C07D 211/76 (2006.01); C07D 213/72 (2006.01); C07D 221/20 (2006.01); C07D 231/12 (2006.01); C07D 233/42 (2006.01); C07D 237/08 (2006.01); C07D 239/24 (2006.01); C07D 241/04 (2006.01); C07D 401/04 (2006.01); C07D 401/14 (2006.01) |